Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Biotechnology Reports Biochemical Findings From Phase IIa Study With Hypertension Vaccine CYT006-AngQb (Medical News Today) |
 |
 |
|
Cytos Biotechnology Ltd (SIX:CYTN) announced results from a biochemical analysis from a phase IIa study (study 02) with the vaccine candidate CYT006-AngQb for the treatment of hypertension. CYT006-AngQb has demonstrated in a first phase IIa study (study 01) a significant reduction of the day-time ambulatory blood pressure of -9 / -4 mmHg (systolic/diastolic) vs. |
